𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A nonclinical safety and pharmacokinetic evaluation of N6022: A first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma

✍ Scribed by Dorothy B. Colagiovanni; Daniel W. Drolet; Emilie Langlois-Forget; Marie-Pier Piché; Doug Looker; Gary J. Rosenthal


Book ID
113965826
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
680 KB
Volume
62
Category
Article
ISSN
0273-2300

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES